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Transformation of primary rodent cells by functions of the adenovirus type 12 (Ad12) early region 1 (E1) is reduced
severalfold compared with transformation by E1 of Ad2. We analyzed whether the unique spacer region of Ad12 E1A that
borders the conserved region (CR) 2 and represents an oncogenic determinant of Ad12 E1A is involved in this impaired
transformation property, putatively by modulating transformation-relevant biological E1A functions. We show that a mutant
(E1ASpm1) that lacks 12 amino-terminal residues of the spacer binds p105-Rb and p130 as Ad12 E1A wild type (E1Awt), whereas
a second spacer mutant (E1ASpm2) that lacks an adjacent stretch of six alanines exhibits highly reduced binding to p105-Rb.
The binding of this mutant to the p130 pocket protein is, however, little impaired. E1ASpm1 diminishes the formation of the
p105-Rb-E2F complex more efficiently than E1Awt or, least efficient, E1ASpm2. These properties of the spacer mutants to target
and to disintegrate the p105-Rb-E2F complex correspond with their ability to transform primary mouse cells in combination
with E1B: E1ASpm1 (plus Ad12 E1B)-transfected cells could be easily established as cell lines, comparable to Ad12 E1Awt- or
Ad2 E1Awt-transfected cells. In contrast, cells transfected with E1ASpm2 or Ad12 E1AdelCR2 (lacking the entire CR2) died within
6–10 weeks after replating, although foci were formed in all cases. Of note, the E1ASpm1-transformed cells grow as fast as the
Ad2 E1Awt-transformed cells, with a doubling rate of 15 h, whereas the doubling of the Ad12 E1Awt-transformed cells takes
;120 h. Moreover, in the established cell lines, the affinity of E1ASpm1 to p105-Rb was higher than with that of E1Awt. Our data
suggest the presence of a transformation-suppressing domain within the carboxyl-terminal 12 residues of the Ad12
E1A-unique spacer, whereas the hydrophobic stretch of six alanines in the spacer is required for stable transformation.
© 1999 Academic Press
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DINTRODUCTION
E1A oncoproteins from human adenoviruses (Ad) re-
rogram quiescent cells to progress from G0/G1 to S
hase, thereby overriding the growth suppressive sig-
als of the untransformed cell (Jansen-Du¨rr, 1996). This
nappropriate up-regulation of the cell cycle can lead to
itosis and, especially in rodent cells, the transformation
f the cells. Functions of E1A alone are able to immor-
alize primary rodent cells (Gallimore et al., 1985; Lynch
nd Trainer, 1989), but in most cases the fully trans-
ormed phenotype can be achieved only by coexpression
f a second oncogene, such as the activated cellular
a-ras (Ruley 1983) or the adenoviral E1B (Williams et al.,
995), that prevents E1A-induced apoptosis (White,
995).
Alternative splicing of the E1A transcription unit gives
ise to five (Ad2/5) or six transcripts (Ad12; Brockmann
nd Esche, 1995). From these, the functions of the 13S
nd 12S mRNA products are most frequently examined.
1A proteins do not bind DNA in a sequence-specific
anner (Ferguson et al., 1985). They mediate all of their
nown functions by physical interactions with cellular
1 To whom reprint requests should be addressed. Fax: 49-(0)201-723-
f974. E-mail: h.-c.kirch@uni-essen.de.
45roteins, such as transcription factors/cofactors like ac-
ivator protein-1, necrosis factor-kB, ATF-2, p300, or TBP
Whyte et al., 1989; Lee et al., 1991; Wang et al., 1993;
eisberg et al., 1994; Zantema and van der Erb, 1995;
arker et al., 1997) or tumor suppressor proteins like
105-Rb (Nevins, 1995; Jones, 1995). Most of these func-
ions involve the nonconserved amino-terminus and/or
he three conserved regions (CR) 1–3 of E1A that are
ighly homologous among different Ad serotypes. As a
esult of these interactions, E1A trans-regulates tran-
cription of its own (Kirch et al., 1993; Kawamura et al.,
993; Pu¨tzer et al., 1997) and of other viral and cellular
enes (Berk et al., 1979; Nevins, 1981; Shenk and Flint,
991). The interaction of E1A with the p105-Rb-E2F trans-
epressor complex (Weintraub et al., 1992) has drawn
uch attention and involves the CR1 and the CR2 (Dyson
t al., 1992): The CR2 domain was found to make the first
ontact between E1A and p105-Rb, allowing the CR1 to
ompete with E2F for the pocket protein binding (Ikeda
nd Nevins, 1993; Fattaey, 1993). The released E2F tran-
cription factor trans-activates several cellular genes
Bagchi et al., 1990) that are required for cell cycle pro-
ression, like DHFR (Slansky et al., 1993), c-myc, and
NA-polymerase (Nevins, 1995).
In contrast to the nononcogenic serotypes (e.g., Ad2),unctions of the E1A plus E1B proteins of the oncogenic
0042-6822/99 $30.00
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46 RUMPF, ESCHE, AND KIRCHerotypes (e.g., Ad12) can induce tumors in immunocom-
etent rodents. The oncogenic determinants are located
ithin the Ad12 E1A proteins (Williams et al., 1995). Al-
hough functionally and structurally related, a considerable
iversity evolved among the E1A genes of oncogenic and
ononcogenic subgroups, especially when the noncon-
erved regions are considered (Brockmann and Esche,
995). Thus in contrast to the E1A proteins of Ad2, a p300-
ndependent transcriptional trans-activation domain is lo-
ated within the 29 amino acids of the amino-terminus
Lipinski et al., 1997). Moreover, Ad12 E1A lacks two tran-
criptional activation domains (AR1 and AR2) that were
ound in Ad5 E1A to be involved in CR3-mediated transcrip-
ional activation (Bondesson et al., 1992; Strom et al., 1998).
nother important difference is the presence of a unique
pacer region in Ad12 E1A that is located between CR2 and
R3. It consists of a block of 20 amino acids that are not
resent in Ad2 E1A (Fig. 1A) and exhibit a considerable
omology to transcriptional suppressor proteins found in
he embryonic development of Drosophila (Licht et al.,
990). Ad5/Ad12 hybrid virus experiments have shown that
he integrity of the spacer is important for the oncogenicity
f the virus (Jelinek et al., 1994; Telling and Williams, 1994).
FIG. 1. Role of Ad12 E1A-specific spacer regions for the physical inter
cids 106–159 of Ad12 E1Awt in comparison with the Ad12 E1A mutants a
roteins with respect to previous findings with Ad2/5 E1A (Barbeau et
130 from 1 mg of (B) U937V or (C) A549 nuclear extracts to 50 mg of
nteraction/Western blot experiments; one fourth of the nuclear proteins
nto the Western blot gel. The lanes A549 NE and U937V NE contain 20
he appearance of p105-Rb and p130 proteins on the blots is indica
ntensive bands in case of the E1A antibody are due to the high levelsespite its additional oncogenic properties, the transforma- tion rate of primary rat cells induced by transfection with
d12 E1A/E1B was ;80% lower as for Ad2 E1A/Ad12 E1B
Lecle´re et al., 1993). CR1 of Ad12 was found to be one
eterminant of the poor Ad12 E1A transformation proper-
ies. Interestingly, an Ad2/Ad12 E1A hybrid protein that
ontains the CR1 of Ad2 and the CR2 plus the spacer of
d12 E1A was still 40% less efficient in transformation
Lecle´re et al., 1993). The poor transformation property of
d12 E1A corresponds with very recent results, where in
ontrast to Ad2 E1A, the expression of Ad12 E1A in human
ells resulted in the prevention of mitosis by S-phase arrest
Grand et al., 1998). Thus because CR2 is nearly identical
etween Ad12 and Ad2/5 E1A, a region carboxyl-terminal
rom the CR2, possibly the spacer, might be involved in the
educed transformation by Ad12 E1A.
Here we examined whether parts of the Ad12 E1A
nique spacer modulate the CR2-dependent binding to
105-Rb or p130, the disruption of p105-Rb- and/or p130-
2F complexes, and a putative participation in the trans-
ormation of primary mouse cells. We provide evidence
or two domains within the spacer that have different
ffects on the pocket protein interaction and transforma-
f E1A with p105-Rb and p130. (A) Schematic presentation of the amino
/5 E1A. The Ad12 unique spacer and the binding domains of the pocket
) are indicated. (B and C) Binding of the pocket proteins p105-Rb and
t GST-Ad12 E1A fusion proteins were examined by combined protein
ound to E1A (from 1 mg originally applied nuclear extract) was loaded
uclear extracts; GSTalone indicates GST-tag without fused E1A proteins.
, p130, and E1A were subsequently detected on the same blot. The
A, released from the GT-Sepharose.action o
nd Ad2
al., 1994
differen
that b
mg of n
ted. Rbion properties of Ad12 E1A.
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47UNIQUE SPACER AND E1A/P105-Rb INTERACTIONRESULTS AND DISCUSSION
The E1A proteins from the oncogenic Ad12 and the
ononcogenic Ad2/5 exhibit differences in their interac-
ion with cellular proteins, resulting in altered oncoge-
icity (Williams, 1995), different transformation capacity
n primary rodent cells (Lecle´re et al., 1993), and opposite
bility to induce mitosis in quiescent human cells (Grand
t al., 1998). In the present study, we examined whether
he Ad12 E1A unique spacer influences the targeting of
he pocket proteins, the disruption of pocket protein-E2F
omplexes, or the transformation properties of Ad12 E1A.
he hydrophobic hexa-alanine stretch in the carboxyl-
erminal half of the Ad12 E1A unique spacer region
articipates in the efficient binding of E1A to p105-Rb
ut not to p130
We analyzed the binding of GST-13S-E1A (E1Awt) or
pacer mutant fusion proteins (Fig. 1A), immobilized on
T-Sepharose, to p105-Rb and p130 from nuclear ex-
racts by in vitro protein interaction analysis and subse-
uent detection of E1A and the E1A-bound pocket pro-
eins by Western blotting. Nuclear extracts were pre-
ared from nearly confluent A549 cells or from U937V
ells at a cell density of 2 3 106 cells/ml medium. Under
hese conditions, p105-Rb and p130 were easily detect-
ble in 20 mg of nuclear extracts from U937V (Fig. 1b)
nd A549 (Fig. 1c) cells. For both cell lines, Ad12 E1Awt
ound 7–15% of the input (with respect to the amount in
uclear extracts, as calculated from the cell control
estern blot signals; Figs. 1, b and c). As shown for Ad5
1A (Barbeau et al., 1994), the Ad12 E1AdelCR2 mutant that
acks the entire CR2 was unable to bind p105-Rb or p130
Figs. 1, a and c), underscoring the prominent role of CR2
s pocket protein targeting domain. The E1ASpm1 mutant
hat lacks the 12 amino-terminal residues of the spacer
Fig. 1a) binds both p130 and p105-Rb as well as E1Awt,
ndicating that this region is dispensable for efficient
inding of Ad12 E1A to p105-Rb and p130. Binding of E1A
o p130 also is only little affected when the hydrophobic
tretch of six alanines in the carboxyl-terminal half of the
pacer are deleted (E1ASpm2 mutant; Fig. 1a). In contrast,
he binding of the E1ASpm2 mutant to p105-Rb was very
eak (Figs. 1, b and c) compared with E1Awt or E1ASpm1.
hus the hexa-alanine stretch in the spacer seems to be
equired for an efficient binding of Ad12 E1A to p105-Rb.
nfluence of the Ad12 E1A spacer mutants on the
ormation of the p105-Rb-E2F and p130-E2F
omplexes
To determine whether the binding properties of the
pacer mutants to the pocket proteins correspond with
he disruption of p105-Rb/p130-E2F complexes, we ex-
mined the formation of these complexes in gel shift
xperiments with the E2F-binding motif from the DHFR sromoter in the presence and absence of the E1A pro-
eins (Fig. 2). For these experiments, 2 mg of nuclear
xtracts from U937V and H596 cells (that do not express
105-Rb; Harbour et al., 1988) were incubated with the
a-32P]dCTP-labeled DHFR-E2F site-containing oligonu-
leotide.
Four complexes (Fig. 2A, a–d) are formed in gel shift
xperiments with the U937V nuclear extracts. Complex b
ontains p105-Rb and complex a contains p130 as
udged from antibody perturbation analysis (Fig. 2A). The
omplex c was previously found to contain free E2F-1
Kirch et al., 1997). In the case of the p105-Rb-deficient
596 cell line, the most shifted complex contained p130
Fig. 2B). The addition of 6 mg of the E1Awt protein
isrupted both the p105-Rb-containing (Fig. 2A) and the
130-containing (Figs. 2, A and B) complexes, whereas
he E1AdelCR2 did not affect any of the complexes (Figs. 2,
and B), supporting the results of the protein interaction
xperiments (Figs. 1, b and c). As E1Awt, 6 mg of both the
1ASpm1 and the E1ASpm2 mutant, respectively, are able to
isrupt the p105-Rb-E2F and p130-E2F complex. Be-
ause these high amounts of E1A proteins might mask a
ine tuning of pocket protein E2F disruption, we exam-
ned whether the spacer modulates this E1A function
sing lower levels of E1Awt, E1ASpm1, and E1ASpm2 GST-
usion proteins (Fig. 3). At 0.5 mg of GST-E1A protein,
isruption of the p105-Rb-containing complex b is incom-
lete for E1Awt and even less effective for E1ASpm2. In
ontrast, the formation of complex b was significantly
educed in the presence of 0.5 mg of the E1ASpm1 mutant
rotein, resulting in a ranking of the order of E1ASpm1 .
1Awt . E1ASpm2 (Fig. 3). This ranking is observed for as
uch as 2 mg of E1A proteins (data not shown), whereas
o difference among the E1Awt, E1ASpm1, and E1ASpm2
roteins was found at 4 mg, even after long exposure of
he gel shift (long exposure, Fig. 3, 4 mg*). Efficient
isruption of the p130-containing complex a requires .4
g of E1A proteins (compare Figs. 2A and 3), possibly
ue to a preferred interaction of E1A with the p105-Rb-
2F complex. All complexes were efficiently competed
y a 10- to 500-fold molar excess of the unlabeled DHFR-
ligonucleotide, whereas an E2F-1-binding site mutant
ligonucleotide [DHFRM; prepared according to the
2/60 mutant described by LaThangue et al. (1990)] had
o effect on the complex formation, except for complex d,
hich was unaffected by a 10-fold but diminished by a
00- and 500-fold excess of DHFRM (Fig. 2C), indicating a
ower affinity of the binding partners compared with the
ther complexes.
In summary, two regions within the Ad12 E1A spacer
ave disparate effects on the interaction of E1A with the
105-Rb pocket protein: The hexa-alanine stretch con-
ributes to the p105-Rb targeting by E1A (Fig. 1b) and
fficiently supports the disruption of p105-Rb-E2F com-
lexes. In contrast, the 12 amino-terminal residues of the
pacer do not seem to contribute to the targeting of
a
a
c
e
u
s
48 RUMPF, ESCHE, AND KIRCHFIG. 2. Disintegration of p105-Rb-/p130-E2F complexes from U973V and H596 cells by E1A proteins. (A) Gel shift experiments using an
-32P-dCTP-labeled oligonucleotide containing the E2F-binding motif of the DHFR promoter and 2 mg of U937V nuclear extracts in the presence or
bsence of either anti-p105-Rb (aRb) or anti-p130 (ap130) antibodies or 6 mg of GST-E1A fusion proteins (as indicated) in comparison with GST alone;
omplexes were labeled a–c, as indicated (see text for details). (B) Gel shift experiments as in A with nuclear extracts from H596 cells that do not
xpress p105-Rb (Harbour et al., 1988); the position of the p130-containing complex is indicated. (C) Gel shift competition experiments using an
nlabeled DHFR oligonucleotide and an E2F-site mutant (DHFRM) oligonucleotide according to the 62/60 mutant described by LaThangue et al. (1990);
indicates supershifted band. *Top of the gel.
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49UNIQUE SPACER AND E1A/P105-Rb INTERACTION105-Rb by E1A (Figs. 1, a and b) and the presence of this
egion in E1A proteins reduces their ability to disrupt the
105-Rb-E2F complex (Fig. 3).
he hexa-alanine stretch and the amino-terminal part
f the spacer express disparate functions in the
ransformation of primary mouse cells
To analyze whether the hexa-alanine stretch and the
mino-terminal part of the spacer have an effect on E1A
unctions in vivo, we examined the transformation prop-
rties of E1A in cooperation with Ad12 E1B by focus
ormation analysis (Table 1). We cotransfected mouse
idney cells prepared from neonatal NMRI mice (days
–7 after birth) with equal amounts (see Materials and
ethods) of the Ad12 or Ad2 E1A and E1B expression
onstructs or with the pRc/RSV eukaryotic expression
ector alone and cultured the cells in 25-cm2 flasks. The
xpression of the respective E1A proteins was shown in
estern blots, and E1B expression was monitored by
T-PCR (data not shown). The transfected cells were
creened for focus formation for as long as 15 weeks.
Except for the E1B control, small foci began to form in
ll cases after 3 weeks of culture. These early small foci
,1 mm in diameter), in which single cells could be
istinguished, were termed “cell clusters,” whereas cell
roupings with high numbers of cells, which exhibit
hree-dimensional growth and were usually .1 mm in
iameter, were termed “foci.” The number and size of the
FIG. 3. Effects of low E1A protein levels on the disintegration of
105-Rb/p130-E2F complexes. Gel shift experiments were performed
s described in Fig. 2 with U937V nuclear extracts in the presence of
ifferent amounts (0.5 and 4 mg) of GST-E1A (E1Awt, E1ASpm1, and
1ASpm2) fusion proteins. 4 mg* indicate long exposure of the gel part, in
hich 4 mg of E1A proteins were used. Numbering of the complexes is
s described in Fig. 2A.arly cell clusters increased for 1–3 additional weeks,nd some of these clusters were considered as foci 5–6
eeks after transfection (Table 1). The number of clus-
ers plus foci for Ad2 E1Awt- or E1ASpm1-transfected cells
as higher (30–40/25 cm2), as in case of the Ad12 E1Awt-,
1AdelCR2-, or E1ASpm2-transfected cells (3–15/25 cm
2).
ells began to spread out from some foci 6–9 weeks
fter transfection (Table 1), and some of the larger foci
egan to detach from the flask surface. At this time, the
ultures including all clusters and foci were trypsinized
nd replated. Trypsinized cells readhered with the Ad2
1Awt-, Ad12 E1Awt-, E1ASpm1-, and E1ASpm2-transfected
ells. The replated Ad2 E1Awt-, Ad12 E1Awt-, and E1ASpm1-
ransfected cells could be established as cell lines. In-
erestingly, the E1ASpm1- and Ad2 E1Awt-expressing cells
ines exhibited a more aggressive growth, with doubling
ates of 15 and 12 h, respectively, than the Ad12 E1Awt-
xpressing cells, which grew slowly with a doubling rate
f 120 h. Thus removal of the carboxyl-terminal part of the
pacer in Ad12 E1A (E1ASpm1) results in comparable
rowth characteristics of the transformed cells as for the
ild-type Ad2 E1Awt. In contrast, replated E1ASpm2-
ransformed cells exhibited no or only very moderate
rowth, and cells died within 10–14 weeks after trans-
ection. This indicates that the six alanines in the spacer
egion of Ad12 E1A are necessary for stable transforma-
ion of primary mouse cells. Interestingly, the same re-
ion is thought to be essential for the oncogenic prop-
rties of E1A, as judged from Ad5/12 hybrid virus exper-
ments (Telling and Williams, 1994; Williams, 1995).
To examine whether the extent of pocket protein bind-
ng by the different E1A proteins in the established
ouse kidney cells (BMK) cell lines was comparable to
hat found in vitro, we analyzed the formation of the
105-Rb-E2F and the p130-E2F complexes by combined
mmunoprecipitation and Western blotting experiments
see Materials and Methods). We examined immunopre-
ipitated p105-Rb complexes for coprecipitated E1A pro-
eins with anti-Ad12 E1A and anti-Ad5 E1A antibodies,
oth of which exhibit cross-reactivity with the E1A pro-
eins from the other species. Due to the different phos-
horylation in vivo, two to four bands were detected with
oth antibodies, where the binding of Ad2 E1A to the
105-Rb protein appeared to be the strongest, followed
y the Ad12 E1ASpm1 mutant and the Ad12 E1Awt protein,
lthough the differences in the binding affinity were less
rominent when the Ad12 E1A antibody was used (Fig.
). In contrast, no significant differences were observed
hen the complex formation between E1A and the p130
ocket protein was examined (data not shown). Thus in
ontrast to the in vitro binding assays, a somewhat
nhanced binding of E1ASpm1 to p105-Rb was found in the
ransformed cells compared with E1Awt. However, these
indings correlate with the results from the gel shift
xperiments (Fig. 3) and with the growth characteristics
f the transformed cell lines (see Table 1).Taken together, we define two domains in the Ad12
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50 RUMPF, ESCHE, AND KIRCH1A unique spacer with opposite abilities in cell trans-
ormation: the amino-terminal part of the spacer seems
o mediate a less aggressive growth of Ad12 E1-trans-
ormed cells, whereas the hydrophobic stretch of six
lanines is indispensable for efficient transformation,
hich corresponds with its importance for the targeting
f p105-Rb by Ad12 E1A.
Oligoalanine stretches, as in Ad12 E1A spacer or in
ther oncogenic Ad like SA7 (Williams, 1995), are a
eature of transcriptional suppressor proteins found in
he embryonic development of Drosophila, like the “Kru¨p-
el” (Kr) zinc finger containing polypeptide (Licht et al.,
990). Interestingly, the transcriptional repressor func-
ions of Kr map within the alanine-rich amino-terminus of
he protein (Licht et al., 1990). If, however, the hexa-
T
Comparison of Focus Formation and Growth Properties after Tr
-E1ASpm1, -E1ASpm2, and -E1AdelCR2; pRc/RSV-Ad
pRc-RSV-
Plasmida
Week after
transfection
No. of cell
clusters
Exp. 1b
No. of
foci
Exp. 1b
No. of cell
clusters
Exp. 2b
No. o
foci
Exp. 2
d12-E1Awt 3 5/2/3 0/0/0 8/13/12 0/0/0
4 11/12/5 0/0/0 11/20/18 0/0/0
5 8/13/6 7/2/0 12/24/20 0/0/0
6 9/13/6 7/2/0 8/14/11 4/10/9
d12-E1AdelCR2 3 1/3/1 0/0/0 8/9/9 0/0/0
6 3/2/2 2/2/5 6/6/9 4/3/1
3 2/4/6 0/0/0 7/12/6 0/0/0
d12-E1ASpm1 4 13/16/18 0/0/0 15/19/12 0/0/0
5 24/27/28 3/4/2 35/31/37 0/0/0
6 26/29/28 4/5/2 35/28/27 4/6/15
d12-E1ASpm2 3 6/5/3 0/0/0 4/7/8 0/0/0
4 12/13/9 0/0/0 7/7/9 0/0/0
5 4/3/3 10/11/8 8/12/11 0/0/0
6 4/2/3 10/13/8 2/3/1 9/15/1
d2-E1Awt 3 9/13/8 0/0/0
4 15/21/19 0/0/0 ND ND
5 21/26/19 10/11/18
6 29/31/25 10/12/9
Rc-RSV 3 3/4/7 0/0/0 6/6/9 0/0/0
6 4/1/3 3/1/3 5/3/6 3/1/3
Rc-RSV-E1B 3 0/0/0 0/0/0 0/0/0 0/0/0
6 1/0/0 0/0/0 0/0/0 0/0/0
ock 3 4/1/5 0/0/0 7/6/9 0/0/0
6 2/2/0 3/1/0 4/2/6 2/4/3
Note. Triplicate values for two experiments (Exp. 1 and Exp. 2 respe
a The cells were transfected with 0.75 mg of pRc/RSV-Ad E1B plus 0
b Small foci (,1 mm in diameter), in which single cells could be disti
xhibit three-dimensional growth and in which no single cell could be
c At 6–9 weeks after transfection, the cultures including all clusterslanine stretch in the Ad12 E1A 13S and/or 12S mRNA- Nncoded proteins mediates repression of cellular genes
nd if such a kind of transcriptional repressor function
ontributes to the transformation properties of Ad12 E1A
emain to be established.
MATERIALS AND METHODS
ell culture
The A549 small cell lung carcinoma cell line (American
ype Culture Collection) was maintained in DMEM, 10%
CS, and 2 mM glutamine. The U937 variant (V) histio-
ytic lymphoma cell line (Kirch et al., 1997; Kloke et al.,
992) and the non-small lung cancer NCI-H596 cell line
kindly provided by Dr. F. Kaye, National Cancer Institute-
tion of Primary Mouse (NMRI) Cells with pRc/RSV-Ad12-E1Awt,
and pRc/RSV Alone Plus pRc/RSV-Ad12 E1B
Clusters and foci
aded 3 established
as cell linesc
Doubling rate
of established
cell lines Comments
Eight weeks after transfection,
Yes 120 h cells spread out from foci
and clusters and grew as
cell lines after trypsination.
No All cells died within 10–14
weeks after transfection.
Yes 15 h At 6–7 weeks after
transfection, cells spread
rapidly from foci and
clusters, and grew as cell
lines after trypsinisation.
No Nine weeks after
transformation, cells spread
from clusters and foci,
readhered after
trypsinisation, but then died
within 4–5 weeks.
Seven weeks after
Yes 12 h transformation, cells spread
and grew rapidly and
remained rapidly growing
as cell lines after
trypsinisation.
No All cells died within 8–10
weeks after transfection.
No All cells died within 7–9
weeks after transfection.
No All cells died within 6–8
weeks after transfection.
) are shown.
of pRc/RSV-E1A constructs.
d, were termed “cell clusters”; cell crowds of . 1 mm in diameter that
uished were termed “foci.”
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51UNIQUE SPACER AND E1A/P105-Rb INTERACTION105-Rb expression (Harbour et al., 1988) were cultured
n RPMI, 10% FCS, and 2 mM glutamine.
1A expression constructs
We generated two spacer mutants of the large, 13S
RNA-encoded wild-type E1A protein (E1Awt), lacking
ither the amino-terminal (E1ASpm1) or the very carboxyl-
erminal part of the spacer consisting of the hydrophobic
la6 stretch (E1ASpm2, Fig. 1A) by primer-introduced se-
uence modification PCR as described previously (Kirch
t al., 1993). These mutants, as well as E1A wild type
E1Awt) and a mutant lacking the CR2 (E1AdelCR2, Fig. 1A),
ere cloned into the pGEX-2T[128/129] bacterial expres-
ion vector (kindly provided by Dr. M. A. Blanar, Depart-
ent of Molecular Biology, Princeton University). After
PTG induction of protein synthesis, the amino-terminal
lutathione-S-transferase (GST)-E1A fusion proteins
ere purified by glutathione (GT)-Sepharose chromatog-
aphy as recently described (Kirch et al., 1998).
ombined protein interaction Western blot
xperiments
Purified GT-Sepharose-bound E1A proteins were used
or protein interaction/Western blot experiments, in
hich 50 mg of E1A proteins was incubated with 1 mg of
wice GT-Sepharose-precleared nuclear extracts that
ere prepared as described previously (Kirch et al.,
997) and washed three times with the incubation buffer
20 mM HEPES, pH 7.4, 0.1% Tween 20, 1 mM NaF, 1 mM
a2VO3, 150 mM NaCl). Subsequently, GST-E1A-bound
uclear proteins were eluted by incubation with 120 ml of
FIG. 4. Analysis of E1A-p105-RB complex formation in the estab-
ished Ad12 E1Awt-, Ad12 E1ASpm1-, and Ad2 E1Awt- plus Ad12 E1B-
ransformed baby BMK cells. Immunoprecipitation was performed as
escribed in Materials and Methods using the anti-105-RB antibody.
he amount of pocket protein-bound E1A proteins was analyzed by
estern blotting using either an anti-Ad12 E1A antibody (*kindly pro-
ided by P. Gallimore) or an anti-Ad5 E1A antibody (M73).aemmli’s buffer at 95°C for 10 min, containing 5% of c-mercaptoethanol, and one fourth of the eluted proteins
as analyzed by Western blotting (Kirch et al., 1997).
mmunoprecipitation
Immunoprecipitation experiments were performed us-
ng 100 mg of nuclear extracts from the Ad12 E1Awt-, Ad12
1ASpm1-, and Ad2 E1Awt- plus E1B-transformed cell lines
nd the IF8-anti-p105-Rb or the C20-anti-p130 antibodies
Santa Cruz) as described previously (Kirch et al., 1999).
he amount of pocket protein-bound E1A proteins was
nalyzed by Western blotting (Kirch et al., 1997) using
ither an anti-Ad12 E1A polyclonal sheep antibody (kind-
y provided by P. Gallimore, CRC Institute for Cancer
tudies, The Medical School, University of Birmingham,
K) or an anti-Ad5 E1A antibody (M73; Santa Cruz).
el shift experiments
For gel shift experiments, the binding of proteins
rom nuclear extracts to the E2F-binding motif from the
HFR promoter was examined in the presence and
bsence of the (GST)-E1A proteins. For these experi-
ents, 2 mg of nuclear extract was incubated with
he[a-32P]dCTP-labeled DHFR-E2F site-containing oli-
onucleotide (59-GGGCTGCGATTTCGCGCCAAACTT-
ACGGCA-39) as recently described (Kirch et al.,
997). For competition experiments, the unlabeled
HFR-E2F site oligonucleotide and an E2F-binding
ite mutant oligonucleotide [GGGCTGCGATTTCGATA-
AAACTTGACGG, according to the E2F-binding defi-
ient E2-promoter-mutant 62/60, described by La
hangue et al. (1990)] were used. For antibody pertur-
ation experiments, nuclear proteins were preincu-
ated with either 0.3 mg of the IF8-anti-p105-Rb anti-
ody (Santa Cruz) or 2 mg of the C20-anti-p130 anti-
ody (Santa Cruz) for 4 h at 4°C before the addition of
he oligonucleotide. For E1A interference analysis, 0.5,
, or 6 mg of recombinant E1A protein was incubated
ith the nuclear proteins for 4 h at 4°C.
oci formation analysis
Mouse kidney cells were prepared from neonatal
MRI mice (days 5–7 after birth). The cells were trans-
ected, using the FuGENE 6 transfection reagent (Boeh-
inger-Mannheim) according to the manufacturer’s pro-
ocol, with 0.75 mg of pRc/RSV-Ad12-E1B plus 0.75 mg of
Rc/RSV-Ad12-E1Awt, -E1ASpm1, -E1ASpm2, -E1AdelCR2, or
Ad2 E1A or with the pRc/RSV eukaryotic expression
ector alone. Cells were cultured in DMEM, 10% FCS,
nd 2 mM glutamine. Medium was changed twice a
eek, and foci formation was determined weekly. All
xperiments were performed in triplicate with 2 3 105ells each.
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